Your browser doesn't support javascript.
loading
Is preoperative radiotherapy suitable for all patients with primary soft tissue sarcoma of the limbs?
Levy, A; Bonvalot, S; Bellefqih, S; Vilcot, L; Rimareix, F; Terrier, P; Belemsagha, D; Cascales, A; Domont, J; Mir, O; Honoré, C; Le Cesne, A; Le Péchoux, C.
Afiliação
  • Levy A; Department of Radiation Oncology, Gustave Roussy, Université Paris Sud, Villejuif, France; Soft Tissue and Bone Sarcoma Multidisciplinary Unit, Gustave-Roussy, Villejuif, France.
  • Bonvalot S; Soft Tissue and Bone Sarcoma Multidisciplinary Unit, Gustave-Roussy, Villejuif, France; Department of Surgery, Gustave-Roussy, Villejuif, France.
  • Bellefqih S; Department of Radiation Oncology, Gustave Roussy, Université Paris Sud, Villejuif, France; Soft Tissue and Bone Sarcoma Multidisciplinary Unit, Gustave-Roussy, Villejuif, France.
  • Vilcot L; Soft Tissue and Bone Sarcoma Multidisciplinary Unit, Gustave-Roussy, Villejuif, France; Department of Radiology, Gustave-Roussy, Villejuif, France.
  • Rimareix F; Soft Tissue and Bone Sarcoma Multidisciplinary Unit, Gustave-Roussy, Villejuif, France; Department of Surgery, Gustave-Roussy, Villejuif, France; Plastic Surgery Unit, Gustave-Roussy, Villejuif, France.
  • Terrier P; Soft Tissue and Bone Sarcoma Multidisciplinary Unit, Gustave-Roussy, Villejuif, France; Department of Pathology, Gustave-Roussy, Villejuif, France.
  • Belemsagha D; Department of Radiation Oncology, Gustave Roussy, Université Paris Sud, Villejuif, France; Soft Tissue and Bone Sarcoma Multidisciplinary Unit, Gustave-Roussy, Villejuif, France.
  • Cascales A; Department of Radiation Oncology, Gustave Roussy, Université Paris Sud, Villejuif, France; Soft Tissue and Bone Sarcoma Multidisciplinary Unit, Gustave-Roussy, Villejuif, France.
  • Domont J; Soft Tissue and Bone Sarcoma Multidisciplinary Unit, Gustave-Roussy, Villejuif, France; Department of Medical Oncology, Gustave-Roussy, Villejuif, France.
  • Mir O; Soft Tissue and Bone Sarcoma Multidisciplinary Unit, Gustave-Roussy, Villejuif, France; Department of Medical Oncology, Gustave-Roussy, Villejuif, France.
  • Honoré C; Soft Tissue and Bone Sarcoma Multidisciplinary Unit, Gustave-Roussy, Villejuif, France; Department of Surgery, Gustave-Roussy, Villejuif, France.
  • Le Cesne A; Soft Tissue and Bone Sarcoma Multidisciplinary Unit, Gustave-Roussy, Villejuif, France; Department of Medical Oncology, Gustave-Roussy, Villejuif, France.
  • Le Péchoux C; Department of Radiation Oncology, Gustave Roussy, Université Paris Sud, Villejuif, France; Soft Tissue and Bone Sarcoma Multidisciplinary Unit, Gustave-Roussy, Villejuif, France. Electronic address: cecile.lepechoux@gustaveroussy.fr.
Eur J Surg Oncol ; 40(12): 1648-54, 2014 Dec.
Article em En | MEDLINE | ID: mdl-25130960
ABSTRACT

AIM:

To evaluate the indications and results of preoperative radiotherapy (RT) on a series of selected patients treated at our institution with curative intent for a limb sarcoma (STS). PATIENTS AND

METHODS:

From 05/1993 to 12/2011, 64 STS patients received preoperative RT.

RESULTS:

RT was delivered as a "limb salvage treatment" prior to surgery for the following reasons as the preferential induction treatment in 53 patients (83%) or as a second intent (17%) after the failure of neoadjuvant systemic chemotherapy/isolated limb perfusion. Surgery was performed after RT in 54 (84%) patients and final limb salvage was performed in 98%. Musculo-cutaneous flap reconstruction was planned upfront in 44% patients, and 19% had a skin graft. Seven patients (13%) had a postoperative RT boost. Thirteen (20%) patients had grade (G) 3/4 adverse events, one after RT and 12 after surgery. At a median follow-up of 3.5 years, the 3-year actuarial overall survival (OS) and distant relapse (DR) rates were 83% and 31%, respectively. Two patients developed a local relapse and two a local progression (non-operated patients). In the multivariate analysis (MVA), histological subtype (leiomyosarcoma) and grade 3 were predictive of poorer survival. Patients with >3 month delay between the start of RT and surgery at our institution had an increased risk of DR in the MVA.

CONCLUSION:

Induction RT should be personalised according to histological subtype, tumour site and risks-benefit ratio of preoperative radiotherapy and is best managed by a multidisciplinary surgical and oncology team in a specialist sarcoma centre.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Terapia Neoadjuvante / Salvamento de Membro / Extremidades Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Surg Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Terapia Neoadjuvante / Salvamento de Membro / Extremidades Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Surg Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article País de afiliação: França